Related Experiment Video
Updated: Feb 5, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Potential targets for the development of new antifungal drugs
Hao Su1, Li Han2, Xueshi Huang3
1Institute of Microbial Pharmaceuticals, College of Life and Health Sciences, Northeastern University, Shenyang, 110819, P. R. China.
Abstract:
In recent years, incidences of invasive fungal infections have greatly increased, especially in immunosuppressed patients, but most today's antifungal drugs are not completely effective due to the development of drug resistance, as well as potential toxicity and adverse effects. Consequently, it is imperative to search for novel antifungal agents to combat fungal infections. This review will discuss the advances in the traditional antifungal therapy, and present an overview of novel strategies for the treatment of fungal infections. The papers presented here highlight new targets that could be exploited for development of new antifungal agents.
Insights
The rise in invasive fungal infections necessitates new antifungal drugs due to resistance and side effects. This review explores advances in antifungal therapy and novel strategies targeting new pathways for effective treatments.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Increasing incidence of invasive fungal infections, particularly in immunocompromised individuals.
- Limitations of current antifungal drugs, including drug resistance, toxicity, and adverse effects.
- Urgent need for novel antifungal agents to address treatment challenges.
Purpose of the Study:
- To review advancements in traditional antifungal therapy.
- To provide an overview of emerging strategies for treating fungal infections.
- To highlight potential new targets for antifungal drug development.
Main Methods:
- Literature review of recent research on antifungal therapies.
- Analysis of traditional and novel approaches to combating fungal infections.
- Identification of new therapeutic targets based on current scientific literature.
Main Results:
- Traditional antifungal therapies face significant challenges with drug resistance and toxicity.
- Novel strategies are being developed to overcome limitations of existing treatments.
- Several new molecular targets show promise for the development of next-generation antifungal agents.
Conclusions:
- Development of novel antifungal agents is crucial to combat rising fungal infections.
- Exploring new targets is essential for creating more effective and safer antifungal drugs.
- Advances in understanding fungal biology offer new avenues for therapeutic intervention.
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
In Vitro Drug Release Testing: Overview, Development and Validation
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Potential Energy
Standard Electrode Potentials

